Sökresultat

Filtyp

Din sökning på "*" gav 125866 sökträffar

LBIC Preclinical User Policy

In accordance with a decision taken at LBIC this user policy will be valid from 2025-01-01 and onward, until a new policy is published. The reason to change from yearly updates is that as LBIC has evolved, our preclinical policy has been condensed into a format that has become less and less subject to change. New policies will always be published on our homepage. For general information about LBIC

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy - 2026-05-03

Usage process

The following process shows what happens when using LBIC and it contains the following steps:Project PlanningUser FeesThe research board and its decisionSupport from LBIC staff for approved projectsScientific resultsOwnership and handling of dataYou can read more about each step on their page in the menu. Applying for scan timeOne question that might arise is how to apply for scan time. This can b

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process - 2026-05-03

Project planning

Projects start with a meeting between the researcher and LBIC staff representing the platform requested. The main goal of this first meeting is to inform each other on the preclinical imaging possibilities available (LBIC) and to identify the scientific questions and needs of the project (researcher). Publications provided by the researcher will be used to establish the strategy of the project. In

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/project-planning - 2026-05-03

User fees

The project costs are calculated taking external (outside LU) as well as internal grants for equipment and staff into consideration. LBIC as a core facility is dependent on external as well as internal funding. In order to keep our machine park well maintained and our research output at the cutting edge we must implement user fees. These fees are predominantly used for maintenance and service cont

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/user-fees - 2026-05-03

The research board and its decisions

All projects performed on LBIC´s preclinical imaging platforms are evaluated before acceptance with respect to possibility to perform the intended experiments successfully, given the available equipment at LBIC. This evaluation is performed by the LBIC preclinical research board (RB). Please note that in the application the intended experiments should be described in their biological or medical co

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/research-board-and-its-decisions - 2026-05-03

Support from LBIC staff for approved projects

LBIC has a limited staff (for staff researchers and other staff members, see homepage). LBIC staff will to the best of their ability help researchers with their projects, given the complexity of the equipment. At present, however, LBIC cannot within its budget provide full service from start to goal for research groups that have received approval for their project.As a general rule, LBIC staff wil

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/support-lbic-staff-approved-projects - 2026-05-03

Scientific results

AcknowledgementsIt is the mission of LBIC to “establish and provide a major translational bio-imaging center at Lund university, combining knowledge in the fields of medical physics, preclinical and clinical medicine, chemistry, technology and applied mathematics in order to develop imaging methods for the advanced study of human morphology, cellular metabolism and physiological function in health

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/scientific-results - 2026-05-03

Ownership and handling of data

Regarding ownership of raw data (spectra, animal and sample images etc.) the juridical situation has been discussed with the LU juridical department. One interpretation can be that LBIC possess ownership of such raw data, but the juridical situation is unclear.LBIC´s policy at present is:LBIC (LU) has the right to use raw data as described above, however it is recommended that prior to public use

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/ownership-and-handling-data - 2026-05-03

News & Events

Meet our scientists: Sharpness and depth that moves research forwardAn article about LBIC and Pia Sundgren.Read the article (in Swedish only at the moment, opens in new window)

https://www.lbic.lu.se/news-events - 2026-05-03

Publications 2018

Preclinical and 7T publications 2018Mostajeran M, Wetterling F, Blixt FW, Edvinsson L, Ansar S. Acute mitogen-activated protein kinase 1/2 inhibition improves functional recovery and vascular changes after ischaemic stroke in rat-monitored by 9.4 T magnetic resonance imaging. Acta Physiol (Oxf). 2018 May; 223(1):e12985, doi: 10.1111/apha.12985Sanchez-Heredia JD, Avendal J, Bibic A, Lau BK. Radiati

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/publications-national-7t-facility/publications-2018 - 2026-05-03

General Information

If you are interested in using our services or need more information about available equipment, services and how to apply under each platform.MicroscopyPreclinical Nuclear MedicinePreclinical Magnetic Resonance ImagingClinical Magnetic Resonance ImagingNational 7 Tesla FacilityUser PolicyUser policy is under revision. For information please contact one of the persons above.AcknowledgementWhen publ

https://www.lbic.lu.se/explore-lbic/general-information - 2026-05-03

About

Lund University Bioimaging Centre (LBIC) is an infrastructure within the Medical Faculty at Lund University, housing a large variety of advanced imaging equipment and cutting-edge bioimaging techniques ranging from micro to macro. This in combination with a highly experienced and service-minded staff makes LBIC unique! Our dedicated staff scientists can offer support throughout the entire experime

https://www.lbic.lu.se/about - 2026-05-03

Publications 2017

Preclinical and 7T publications 2017Wasserstrom S, Morén B, Stenkula KG. Total Internal Reflection Fluorescence Microscopy to Study GLUT4 Trafficking. Methods Mol Biol. (2018) 1713:151-159. Published online 08 December 2017.Horstmann P.F., Raina D.B. , Isaksson H., Hettwer W., Lidgren L., PetersenM.M., Tägil M. Composite Biomaterial as a Carrier for Bone-Active Substances for Metaphyseal Tibial Bo

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/publications-national-7t-facility/publications-2017 - 2026-05-03

Publications 2016

Preclinical and 7T publications 2016Gottschalk M, Troprès I, Lamalle L, Grand S, Le Bas JF, Segebarth C. Refined modelling of the short-T2 signal component and ensuing detection of glutamate and glutamine in short-TE, localised, (1) H MR spectra of human glioma measured at 3 T. NMR Biomed. 2016 Jul;29(7):943-51. doi: 10.1002/nbm.3548Hansen JS, Krintel C, Hernebring M, Haataja TJK, de Marèa S, Wass

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/publications-national-7t-facility/publications-2016 - 2026-05-03

Publications 2015

Preclinical and 7T publications 2015Erlandsson L, Nääv Å, Hennessy A, Vaiman D, Gram M, Åkerström B, Hansson SR. Inventory of Novel Animal Models Addressing Etiology of Preeclampsia in the Development of New Therapeutic/Intervention Opportunities. Am J Reprod Immunol. 2016 Mar;75(3):402-10. doi: 10.1111/aji.12460. Epub 2015 Dec 18.Ahlstedt J., Tran T.A., Strand S-E, Gram M., Åkerström B. Human Ant

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/publications-national-7t-facility/publications-2015 - 2026-05-03